We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ICPT market cap is 794.69M. The company's latest EPS is USD 5.3033 and P/E is 3.58.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 77.59M | 77.22M | 67.96M | 83.72M | 88.79M |
| Operating Income | -10.14M | -17.99M | -31.63M | -7.12M | -4.62M |
| Net Income | -133.05M | 379.67M | -32.14M | -5.86M | -2.79M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 179.8M | 252M | 312.69M | 363.47M | 285.71M |
| Operating Income | -285.49M | -312.43M | -231.24M | -55.67M | -68.22M |
| Net Income | -309.24M | -344.68M | -274.88M | -91.43M | 221.82M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 559.4M | 553.71M | 504.09M | 484.64M | 393.16M |
| Total Liabilities | 451.73M | 460.63M | 436.9M | 417.09M | 321.32M |
| Total Equity | 107.68M | 93.08M | 67.19M | 67.55M | 71.85M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 509.17M | 754.89M | 580.49M | 527.02M | 553.71M |
| Total Liabilities | 490.04M | 703.33M | 747.34M | 710.99M | 460.63M |
| Total Equity | 19.13M | 51.56M | -166.85M | -183.96M | 93.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.97M | -26.78M | -51.6M | -74.9M | -58.21M |
| Investing | 316.78M | 261.85M | 59.32M | 156.27M | 216.04M |
| Financing | -261.64M | -267.32M | -254k | -297k | -110.3M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -240.71M | -236.61M | -170.03M | -41.64M | -26.78M |
| Investing | -48.07M | -188.99M | 162.82M | 70.73M | 261.85M |
| Financing | 263.55M | 457.52M | -693k | 1.12M | -267.32M |
| Market Cap | 794.69M |
| Price to Earnings Ratio | 3.58 |
| Price to Sales Ratio | 2.78 |
| Price to Cash Ratio | 15.73 |
| Price to Book Ratio | 8.54 |
| Dividend Yield | - |
| Shares Outstanding | 41.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.36 (1.89%) |
| Company Name | Intercept Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.interceptpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
